BTI is establishing collaborations, joint ventures, partnerships and technology alliances with agricultural, chemical, pharmaceutical and biotechnology companies.    The Company also is interested in licensing its technologies and products to manufacturers and distributors.   BTI provides the following advantages to our business partners:      ·  Unique intellectual property and R&D capability ·  Robust growth potential with a diversified IP portfolio ·  Assets that involve a balance of market-ready and development-stage products ·  Leading-edge technology and proprietary approaches                 FOR FURTHER DETAILS, PLEASE CONTACT:   Lee A. Bulla, Ph.D. President, Chief Executive Officer PO Box 35187 2110 Research Row, Suite 555 Dallas, TX 75235-0187 Phone: 214-280-4935  E-mail: labulla@biologicaltargets.com